← Back to Search

Behavioural Intervention

Digital Intervention for Depression

N/A
Waitlist Available
Research Sponsored by University of Texas at Austin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up daily over 4 weeks
Awards & highlights

Study Summary

This trial tests a digital intervention to reduce depression and rumination in individuals with elevated symptoms. Participants use the intervention for 4 weeks & complete daily & weekly surveys.

Who is the study for?
This trial is for individuals with moderate or severe depression symptoms who focus more on sad faces, can give informed consent, speak English fluently, and have stable medication use. They need a smartphone and computer access but cannot join if they heavily use alcohol or have serious mental illnesses like schizophrenia.Check my eligibility
What is being tested?
The study tests a gamified app designed to shift attention away from negative stimuli as a treatment for depression. Participants will engage with the app daily over four weeks and complete short surveys plus weekly assessments.See study design
What are the potential side effects?
Since this is a digital intervention focusing on attention training through an app, there are no direct physical side effects expected. However, users may experience frustration or lack of interest in the game-like tasks.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~daily over 4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and daily over 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Patient Health Questionnaire - 8 (PHQ-8)
Secondary outcome measures
Anxiety
Perseverative Thinking Questionnaire (PTQ) -"Difficult to Disengage from" subscale
Ruminative Response Scale - Brooding subscale (RRS-B)
Other outcome measures
Attention bias (mousetracking)
General Rumination

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Gamified Attention Bias ModificationActive Control1 Intervention
Digital therapeutic intervention based on Attention Bias Modification Training (ABMT) designed to decrease negative attention bias.
Group II: Gamified Placebo TrainingPlacebo Group1 Intervention
Identical version of the gamified behavioral intervention without manipulation designed to decrease negative attention bias

Find a Location

Who is running the clinical trial?

University of Texas at AustinLead Sponsor
350 Previous Clinical Trials
80,874 Total Patients Enrolled
30 Trials studying Depression
5,169 Patients Enrolled for Depression

Media Library

Gamified Attention Bias Modification (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05601362 — N/A
Depression Research Study Groups: Gamified Attention Bias Modification, Gamified Placebo Training
Depression Clinical Trial 2023: Gamified Attention Bias Modification Highlights & Side Effects. Trial Name: NCT05601362 — N/A
Gamified Attention Bias Modification (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05601362 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there still an opportunity to join this research endeavor?

"Per clinicaltrials.gov, this medical trial has ceased accepting participants - the initial posting of which was on September 1st 2023 and its last update occurring in November 30th 2022. At present, there are 1290 other trials available that require recruitment of patients."

Answered by AI

Who has the potential to partake in this research endeavor?

"This medical trial is seeking to enrol 100 individuals with depressive symptoms aged between 18-45. To be considered, applicants must have normal or corrected vision; proficient English language skills; PHQ-8 rating of 10+; an attention bias task score higher than 6500 ms on sad faces; remain stable on any psychiatric and neurological medication they are taking; access to a smartphone for downloading the app and a laptop/desktop device to complete weekly assessments. These criteria should all be met in order for potential participants to provide informed consent."

Answered by AI

Are individuals over 40 years of age being considered for this trial?

"As per the trial requirements, only adults between 18 and 45 are eligible to participate."

Answered by AI

Who else is applying?

What state do they live in?
Louisiana
Texas
What site did they apply to?
Mary Eileen McNamara
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
3+
Recent research and studies
clinicaltrials.govStudy
Evaluation of a Therapeutic Mobile App for Depression
2023. "Evaluation of a Therapeutic Mobile App for Depression". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05601362.
All > Depression Austin
~8 spots leftby May 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top